Screening for gestational diabetes mellitus in a South African population: Prevalence, comparison of diagnostic criteria and the role of risk factors
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of gestational diabetes mellitus (GDM) is increasing. Most major world organisations now recommend universal screening for GDM based on the International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria. Currently there is a lack of consensus on the diagnostic criteria for GDM used in South Africa (SA). The Society for Endocrinology, Metabolism and Diabetes of South Africa's revised guidelines recommend the use of the IADPSG criteria for the diagnosis of GDM. OBJECTIVES: To determine the prevalence of GDM in an SA population. We compared the prevalence of GDM using the various diagnostic criteria and evaluated the risk factors associated with GDM. METHODS: This was a prospective cohort observational study carried out at a level 1 clinic in Johannesburg, SA. All pregnant women at <26 weeks' gestation were recruited. Patients known to have GDM were excluded. At recruitment, a data questionnaire was completed and bloods were drawn for a random glucose test and measurement of the glycated haemoglobin level. A 75 g 2-hour oral glucose tolerance test (OGTT) was scheduled before 28 weeks' gestation. RESULTS: Five hundred and fifty-four patients (55.4%) completed the OGTT. The prevalence of GDM was 25.8% if universal screening and the IADPSG criteria were used. If universal screening and the National Institute for Health and Care Excellence (NICE) criteria were used, the prevalence was 17.0%. If selective risk factor-based screening was used, only 254 (45.8%) of the women would have had an OGTT. The prevalence of GDM in this instance would have been 15.2% with the IADPSG criteria and 3.6% with the NICE criteria. Two hundred and fifty-four patients (45.8%) had at least one risk factor for GDM. The presence of one or more risk factors had a poor sensitivity (58.7%) and specificity (58.6%) for the detection of GDM in our study population. CONCLUSIONS: The prevalence of GDM would be substantially increased if universal screening with the IADPSG criteria were to be employed. Risk factors are a poor screening test for GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Screening criteria for high-risk gestational diabetic patients
O'Sullivan, J. B., Mahan, C. M., Charles, D., & Dandrow, R. V. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33833-9 · Cited by 478 · cited 1×
“It has also been found to have poor sensitivity and specificity in other studies.[14,15] Furthermore, a major challenge of selective screening is that it places a high demand on the healthcare worker to identify patients who should be screened.”
BackgroundGestational Diabetes Mellitus in Africa: A Systematic Review
Macaulay, S., Dunger, D. B., & Norris, S. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097871 · Cited by 163
Effect of selective screening for gestational diabetes.
Williams, C. B., Iqbal, S., Zawacki, C. M., Yu, D., Brown, M. B., & Herman, W. H. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.418 · Cited by 57
Cited by
Lee, K. W., Ching, S. M., Ramachandran, V., Yee, A., Hoo, F. K., Chia, Y. C., Wan Sulaiman, W. A., Suppiah, S., Mohamed, M. H., & Veettil, S. K. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2131-4 · Cited by 546
Behboudi-Gandevani, S., Amiri, M., Bidhendi Yarandi, R., & Ramezani Tehrani, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0406-1 · Cited by 321
Saeedi, M., Cao, Y., Fadl, H., Gustafson, H., & Simmons, D. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108642 · Cited by 234
Muche, A. A., Olayemi, O. O., & Gete, Y. K. (2019) · Archives of Public Health · doi:10.1186/s13690-019-0362-0 · Cited by 128
“A total of 9 articles [15, 43–45, 48, 50, 56, 57] were included to see the association of history of chronic hypertension and GDM, of which 4 of them [15, 44, 50, 56] have shown a significant association with GDM.”
BackgroundResultNwali, S. A., Onoh, R. C., Dimejesi, I. B., Obi, V. O., Jombo, S. E., & Edenya, O. O. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04168-8 · Cited by 18
“Selective screening for GDM has been shown to have poor sensitivity and poor positive predictive value[16, 24].”
BackgroundMethodResultInfluentialMghanga, F., Maduhu, E., & Nyawale, H. (2020) · Ghana Medical Journal · doi:10.4314/gmj.v54i2.5 · Cited by 11
Hinzmann, R., Militz, D., Zima, T., Špaček, M., Storm, H., Chapanduka, Z., & Hauss, O. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108860 · Cited by 2
Metadata
- Authors
- Adam, S., & Rheeder, P.
- Venue
- South African Medical Journal
- Published
- 2017-05-24
- Volume
- 107
- Issue
- 6
- Pages
- 523
- ISSN
- 0256-9574 (ISSN-L)
- 2078-5135
- OpenAlex
- W2618794645
- Cited by
- 116
- References
- 4
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.